RIGOL Technologies (00537.HK): Offer Price Fixed at HK$45.98 per H Share, Expected Listing on July 9
RIGOL Technologies Co., Ltd. (Stock Code: 00537) announced that on 7 July 2026, the offer price has been fixed at HK$45.98 per H share (excluding 1% brokerage commission, 0.0027% SFC transaction levy, 0.00565% Stock Exchange trading fee and 0.00015% AFRC transaction levy). The company expects to announce the level of interest in the international offering, the level of applications in the Hong Kong public offering, the basis of allocation of Hong Kong offer shares and the results of the Hong Kong public offering on 8 July 2026 in the manner described in the prospectus. Assuming the global offering becomes unconditional on or before 8:00 a.m. (Hong Kong time) on 9 July 2026 (Thursday), trading of the H shares is expected to commence on the Stock Exchange at 9:00 a.m. (Hong Kong time) on 9 July 2026 (Thursday). The H shares will be traded in board lots of 100 H shares each, with a stock code of 00537.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- XINTE ENERGY (01799.HK): Nan Xinjian Resigns as General Manager and Executive Director; Wang Bin Appointed General Manager and Proposed as Executive Director
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction